1. Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder

   • Peter Lepping
   • Markus Huber

   Current Opinion 29 August 2012 Pages: 721 - 728

   

2. Management of Neuropsychiatric Symptoms in People with Dementia

   • Clive Ballard
   • Anne Corbett

   Therapy in Practice 29 August 2012 Pages: 729 - 739

   

3. The Association between Conventional Antidepressants and the Metabolic Syndrome

   • Roger S. McIntyre
   • Ka Young Park
   • Sidney H. Kennedy

   Review Article 29 August 2012 Pages: 741 - 753

   

4. Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms

   • Daniel F. Connor
   • Robert L. Findling
   • Gerald Tremblay

   Original Research Article 29 August 2012 Pages: 755 - 768

   

5. Escitalopram

   • Karly P. Garnock-Jones
   • Paul L. McCormack

   Adis Drug Evaluation 29 August 2012 Pages: 769 - 796

   

6. Pharmacoeconomic Spotlight on Varenicline as an Aid to Smoking Cessation†

   • Gillian M. Keating
   • Katherine A. Lyseng-Williamson

   Adis Spotlight 29 August 2012 Pages: 797 - 800

7. Carotid Intima-Media Thickness

   • Christian Saleh

   Correspondence 29 August 2012 Pages: 801 - 803

8. The Author’s Reply

   • Pedro J. Modrego

   Correspondence 29 August 2012 Pages: 803 - 804